- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Endovia Health Sciences, Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| ENDOVIA HEALTH SCIENCES Aktie jetzt für 0€ handeln | |||||
| Di | Endovia Health Sciences, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.10. | Endovia Health Sciences, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 05.10. | Endovia Health Sciences, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 05.10. | Endovia Health Sciences: Endovia and Lupvindol BioSciences Announce FDA Determination that CannEpil for Canine Bone Cancer Pain Qualifies as a Minor Use, Establishing Eligibility for Conditional Approval Pathway | 158 | GlobeNewswire (Europe) | FORT LAUDERDALE, Fla., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Endovia Health Sciences, Inc. ("Endovia" or the "Company") (NYSE American: EDVA), in association with Lupvindol BioSciences ("Lupvindol"),... ► Artikel lesen | |
| 23.09. | Endovia Health Sciences (EVDA) Stock Soars 48% After-Hours: Here's What's Going On | 7 | Benzinga.com | ||
| 22.09. | Endovia Health Sciences, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 22.09. | Endovia Health Sciences Closes Initial Funding to Accelerate CannEpil Development Amid Growing Federal Support for Botanical Drug Pathways | 272 | GlobeNewswire (Europe) | Initial tranche assists CannEpil® development and commercialization Financing comes as FDA and Congress increase focus on advancing and incentivizing regulated development of botanical and plant-derived... ► Artikel lesen | |
| 31.08. | Endovia Health Sciences Welcomes Historic Shift in Federal Cannabinoid Policy; Advances CannEpil FDA Submission and Expands Development Pipeline | 317 | GlobeNewswire (Europe) | Company views federal support for Schedule III as a significant evolution in U.S. cannabinoid policy and an important step toward a durable regulatory framework for cannabinoid-based medicines and... ► Artikel lesen | |
| 25.08. | Endovia Health Sciences, formerly Splash Beverage, Achieves First FDA Regulatory Milestone for CannEpil Veterinary Development Program | 347 | GlobeNewswire (Europe) | FORT LAUDERDALE, Fla., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Endovia Health Sciences, Inc. (NYSE American: EDVA), formerly Splash Beverage Group, Inc. (NYSE American: SBEV) ("Endovia Health" or the "Company")... ► Artikel lesen | |
| 25.08. | Endovia Health Sciences, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 21.08. | Splash Beverage to rename as Endovia Health Sciences; shares up | 1 | Seeking Alpha | ||
| 21.08. | Splash Beverage Group to Become Endovia Health Sciences; New NYSE American Ticker "EDVA" Effective Monday | 402 | GlobeNewswire (Europe) | FORT LAUDERDALE, Fla., Aug. 21, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) (the "Company") today announced that its corporate name will change to Endovia Health Sciences... ► Artikel lesen | |
| 20.08. | SPLASH BEVERAGE GROUP, INC. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
| 20.08. | Splash Beverage Group GAAP EPS of -$2.30 | 1 | Seeking Alpha | ||
| 20.08. | SPLASH BEVERAGE GROUP, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 20.08. | Splash Beverage Group: Splash Beverage Reports Second Quarter 2026 Results and Highlights Strategic Transformation Toward Endovia Health Sciences | 335 | GlobeNewswire (Europe) | FORT LAUDERDALE, Fla., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) ("Splash" or the "Company") today reported financial results for the second quarter ended... ► Artikel lesen | |
| 19.08. | SPLASH BEVERAGE GROUP, INC. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 17.08. | SPLASH BEVERAGE GROUP, INC. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | - | SEC Filings | ||
| 12.08. | Splash Beverage will officially become Endovia Health Sciences on August 21 | 1 | Seeking Alpha |
1 2 3 Weiter >>
52 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 60,34 | +0,20 % | BrightSpring Health Services, Inc. - 10-Q, Quarterly Report | ||
| LIFESTANCE HEALTH GROUP | 13,635 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,920 | -1,33 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat FMC auf "Underweight" mit einem Kursziel von 32,30 Euro belassen. Entgegen seinen Erwartungen seien die Konsensschätzungen an die Quartalszahlen... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 8,020 | -0,50 % | Alignment Healthcare Q3 2026 Earnings Call Transcript | ||
| SIEMENS HEALTHINEERS | 43,190 | +0,70 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS | 47,765 | +1,63 % | BERENBERG stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius von 50 auf 54 Euro angehoben und die Einstufung auf "Buy" belassen. Der Markt bewerte den Medizinkonzern als vom... ► Artikel lesen | |
| HEARTFLOW | 60,55 | +0,03 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| BILLIONTOONE | 114,75 | -0,08 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| GENEDX | 70,98 | -0,06 % | GeneDx plans to add long-read genome sequencing to portfolio | ||
| CONCENTRA GROUP | 41,250 | 0,00 % | Biotech Stocks At 52-Week Highs - Retension Pharmaceuticals Rises With IPO, Biogen, Concentra Group, Hinge Health, HealthStream | WESTON (dpa-AFX) - The following biotech stocks reached a 52-week high on October 12, 2026, driven by catalysts such as achieving promising clinical data or a public offering.Biogen Inc. (BIIB)Biogen... ► Artikel lesen | |
| GERRESHEIMER | 33,040 | +3,57 % | Kurssprünge und neue Aufträge: Wie belastbar ist die Wende? dynaCERT, Gerresheimer, Steyr Motors | Ein Übernahmeangebot, internationale Vertriebsfortschritte und ein Konzernumbau bringen Bewegung in die folgenden drei Börsenwerte. Während Anleger auf neue Wachstumsimpulse und finanzielle Entlastung... ► Artikel lesen | |
| ANTERIS TECHNOLOGIES GLOBAL | 6,420 | 0,00 % | ANTERIS TECHNOLOGIES GLOBAL CORP.: Schedule 14A Preliminary Proxy Statement | ||
| STARLING ONCOLOGY INSTITUTE | 6,650 | 0,00 % | The Oncology Institute Rebrands as Starling Oncology | CERRITOS, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI" or "the Company"), one of the largest value-based oncology groups in the United States, announced today that... ► Artikel lesen | |
| MIMEDX | 3,975 | +0,13 % | Mizuho cuts MiMedx stock price target on wound segment weakness | ||
| KESTRA MEDICAL TECHNOLOGIES | 30,580 | 0,00 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results | KIRKLAND, Wash., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results... ► Artikel lesen |
Das Unternehmen ENDOVIA HEALTH SCIENCES INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,163 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ENDOVIA HEALTH SCIENCES INC finden Sie auf Wallstreet Online.